Pfizer says 3 COVID shots protect children under 5
Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday, another step toward shots for the littlest kids possibly beginning in early summer.
Theories emerge for mysterious liver illnesses in children
Health officials remain perplexed by mysterious cases of severe liver damage in hundreds of young children around the world.
A step closer to treatment for the most common form of blindness
Scientists at The University of Manchester have taken an important step towards finding a treatment for age-related macular degeneration (AMD), the most common form of adult blindness in the developed world. The researchers were able to identify early signs of the disease which could be targeted by new treatments before symptoms develop. The study is published in PNAS.
EXPLAINER: What is monkeypox and where is it spreading?
European and American health authorities have identified a number of monkeypox cases in recent days, mostly in young men. It’s a surprising outbreak of a disease that rarely appears outside Africa.
CDC urges Pfizer booster for children ages 5 to 11
Kids ages 5 to 11 should get a booster dose of Pfizer’s COVID-19 vaccine, advisers to the U.S. government said Thursday. The Center for Disease Control and Prevention quickly adopted the panel’s recommendation, opening a third COVID-19 shot to healthy elementary-age kids — just like what is already recommended for everybody 12 and older.
